CACI completes transaction to acquire Emergint Technologies

CACI International Inc (NYSE: CACI) announced today that it has completed its transaction to acquire Emergint Technologies, Inc., a premier provider of emerging technology solutions focused on the data-driven needs of national health organizations. This acquisition builds on CACI's healthcare IT capability and expands its presence in the growing healthcare IT market.

Founded in 1999, Emergint has 300 employees and is headquartered in Louisville, Kentucky. The company offers a wide range of healthcare-focused IT-related services that support the missions of federal and state customers. Its workforce has extensive experience providing health data integration and analysis solutions, management and IT consulting, and data and records management. Emergint has contract vehicles with key health-focused federal agencies, including the Centers for Disease Control and Prevention, National Institutes of Health, and U.S. Food and Drug Administration. Its 2012 revenue is expected to be approximately $42 million, and the acquisition is expected to be accretive to CACI's earnings per share during its first 12 months.

John Mengucci, CACI Chief Operating Officer and President of U.S. Operations, said, "Emergint Technologies, Inc. is a wonderful addition to the CACI team, and their best-in-class capabilities in data analytics, integration, and analysis will greatly enhance our healthcare IT practice. Furthermore, we are positive that their commitment to integrity and client service will make them an excellent fit for our company and culture."

According to Dan Allen, CACI President and Chief Executive Officer, "As the public health community continually focuses on increasing data information exchange and delivering improved results to enhance patient care, Emergint is a valuable addition to the CACI team. Their established relationships with federal health organizations will help us to further expand our footprint in the high-growth healthcare IT market."